Why is Ishita Drugs falling/rising?

As of 30-Jun, Ishita Drugs & Industries Ltd is currently priced at 83.00, reflecting an increase of 0.85 or 1.03%. The stock has shown strong performance recently, outperforming its sector by 0.34% today and trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has risen by 11.41%, and in the last year, it has generated a return of 24.33%, significantly higher than the broader market's return of 3.95%. However, there has been a decline in investor participation, with delivery volume falling by 45.3% compared to the 5-day average. The company has an attractive valuation with a Price to Book Value of 2.5 and a return on equity (ROE) of 8.8, indicating that it is trading at a discount compared to its peers. In the broader market context, the stock's recent performance has outpaced the benchmark, as evidenced by its 1-week return of 11.41% compared to the Sensex's 2.09%. Despite this positive short-term trend, concerns about long-term fundamentals persist, including a weak average ROE of 8.34% and sluggish growth in net sales and operating profit over the past five years. These factors may contribute to a cautious outlook among investors, despite the stock's current upward movement.